VCNX — Vaccinex Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $2.20m
- $2.78m
- $0.60m
Brief: Vaccinex Announces Activation Of Clinical Sites To Enroll Patients In Studies Of Pepinemab As Single Agent In Alzheimer’S Disease
Brief: Vaccinex Reports Q1 Results
Brief: Vaccinex Reports Publication Of Results From Trial In Non-Small Cell Lung Cancer In Peer-Reviewed Journal
Brief: Vaccinex Reports Fourth Quarter 2020 Financial Results
Vaccinex Inc: Gains on licensing antibody to Surface Oncology
Brief: Vaccinex Announces Licensing Of Anti-Ccr8 Antibody To Surface Oncology
U.S. STOCKS ON THE MOVE-Casa Systems, Baidu, Applied Materials, Evolus
U.S. STOCKS ON THE MOVE-JinkoSolar, Riot, Bloomin' Brands, Six Flags
Brief: Vaccinex Announces Signing Of Two Multi-Project Deals With Leading Pharmaceutical Companies Focused On Leveraging Its Activmab Platform
Vaccinex Inc: Surges on multi-project deals
Brief: Vaccinex Ends Q3 With Cash And Cash Equivalents Of $17.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:21 PM
Vaccine expert flags uncertainty around required efficacy levels for COVID-19 vaccines - SVB Leerink
U.S. STOCKS ON THE MOVE-SolarEdge Technologies Inc, Snowflake Inc, Koppers Holdings Inc, Fulgent Genetics Inc
U.S. STOCKS ON THE MOVE-Tesla Inc, Nikola Corp, AutoZone Inc, GameStop Corp
Vaccinex set for record low after Huntington's treatment fails to meet goal
Brief: Vaccinex Says Pepinemab Was Well-Tolerated In Phase 2 SIGNAL Study
NASDAQ RESUMED AT 08:01 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM